Export

Ritonavir
Essential medicine status
General description
Ritonavir is recommended for use in combination with other protease inhibitors as a pharmacological booster in the prevention and treatment of HIV/AIDS, and not as an antiretroviral in its own right.
INN
Ritonavir
Medicine type
Chemical agent
Therapeutic equivalent for
Wikipedia
DrugBank
Recommendations
Section
Antiretrovirals > Protease inhibitors
  • Oral > Liquid: 400 mg per 5 mL
  • Oral > Solid: 25 mg tablet (heat stable); 100 mg tablet (heat stable)
  • Oral > Other: 100 mg powder